KATHY EFFLE-MEYER: Open Payments
NPI 1134159940 · NORFOLK, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$257 in 18 payments from 6 companies in 2025. Trend: 2023 $237 · 2024 $331 · 2025 $257
Food & beverage: $257
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $146 |
| Novo Nordisk Inc | 2 | $35 |
| Merck Sharp & Dohme LLC | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: UBRELVY, QULIPTA, Wegovy, LINZESS, PROQUAD, REXULTI, Veozah, XIFAXAN.
Industry payments across NE — which companies pay providers there.
